Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Elmet Group Wins $36M Contract from Defense Logistics Agency
The Elmet Group's subsidiary, Elmet Technologies, was awarded a $36 million contract by the Defense Logistics Agency (DLA) to supply high-performance molybdenum and tungsten alloys and precision wire. These materials will be supplied to the U.S. National Defense Stockpile for use in jet engine components and other aerospace applications. This award follows a much larger $2 billion DLA contract announced earlier in the month, further solidifying the company's role as a critical domestic supplier of refractory metals.
Sizzle Acquisition Corp. II M&A Deal with Trasteel Holding S.A.
Sizzle Acquisition Corp. II entered into an amendment to its existing business combination agreement with Trasteel Holding S.A. to extend the PCAOB audit delivery deadline to September 30, 2026. The amendment also specifies that the post-closing board of directors will consist of five members, with four appointed by Trasteel and one by Sizzle II.
Integer Holdings Corporation received early termination of the HSR Act waiting period for its pending $5.7 billion acquisition by KKR affiliates. This regulatory milestone satisfies a key closing condition for the merger, which is expected to close by the end of 2026 following a stockholder vote on October 21, 2026.
Celcuity Inc. announced the commercial availability of REVTORPYK™ (gedatolisib) in the United States for patients with HR+/HER2- advanced breast cancer without a PIK3CA mutation. The therapy, which was FDA-approved in July 2026, is the first to inhibit all class I PI3K isoforms and mTOR complexes to blockade the PAM pathway. The company has also launched the REVTORPYK Support Services program to assist with patient access and financial assistance.
Iron Horse Acquisition II M&A Deal with Electra Vehicles, Inc.
Iron Horse Acquisition II Corp. (IRHO) provided a status update on its pending merger with Electra Vehicles, Inc., an AI battery intelligence company. The update highlights new customer wins for Electra, including Mooving and Omega Seiki Mobility, and progress toward the Nasdaq listing five months after signing the definitive business combination agreement.
The Crypto Company has launched the private beta testnet for Frame, its quantum-resistant Layer 1 blockchain. The network is designed for sub-two-second settlement and utilizes NIST-standard post-quantum digital signatures (ML-DSA-87) to ensure long-term security against quantum computing threats.
“Frame’s testnet going live is a real milestone, and I am excited about how far the team has come and what Frame is going to be. It is amazing to watch transactions flowing on-chain and see people lighting up when they experience for themselves what this platform really unlocks.”
Ron Levy, Chief Executive Officer of TCC
“We set out to build a Layer 1 that is quantum-resistant from genesis, and now we have one, designed for settlement in under two seconds. That combination lets people and agents move across chains without waiting, and without worrying about tomorrow’s threats.”
Aperture AC M&A Deal with Valley Oasis Development LLC
Aperture AC's merger target, Atlantic HPC Group Inc, completed the acquisition of 100% of Valley Oasis Development LLC, a Tennessee-based entity holding 29 MW of contracted power capacity. The acquisition increases Atlantic's total utility-approved capacity to 127 MW across four states as it prepares for its business combination with Aperture. The site is zoned for heavy industrial use, making it suitable for bitcoin mining and AI compute deployments.
Rafael Holdings announced topline results from its pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo in 94 patients with Niemann-Pick Disease Type C. While the study did not achieve statistical significance on the primary endpoint in the overall population, a prespecified analysis of patients on background therapy (83% of the study) showed a statistically significant slowing of disease progression. The company remains on track to submit a New Drug Application (NDA) to the FDA in the fourth quarter of 2026.
Professional Diversity Network Nasdaq/NYSE Compliance Notice
Professional Diversity Network, Inc. has regained compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing. The company's common stock maintained a closing bid price at or above $1.00 for 10 consecutive business days following a previously announced reverse stock split. Nasdaq has officially closed the matter, resolving the deficiency notice originally issued on June 5, 2026.
Jade Biosciences announced preclinical data for JADE301, an anti-interferon beta monoclonal antibody being developed for dermatomyositis. The data demonstrated high-affinity binding, potent inhibition of downstream signaling, and a differentiated pharmacokinetic profile supporting infrequent subcutaneous dosing. The company expects to initiate a Phase 1 clinical trial in healthy volunteers in Q4 2026, with interim data anticipated in the second half of 2027.
Onar Holding Signs $27.8M M&A Deal with Advertise Purple LLC
ONAR Holding Corporation completed the acquisition of Advertise Purple LLC, a leading affiliate marketing agency, for total consideration of up to $27.825 million. The deal includes $12.825 million in cash, a $7.0 million promissory note, and up to $8.0 million in potential earnout payments based on gross profit thresholds through 2029. The acquisition is described as the largest in ONAR's history, significantly increasing its pro forma revenue and adding the Bloom data and analytics platform to its technology division.
Connect Biopharma announced positive topline results from its global Phase 2 study of rademikibart as an add-on treatment for acute exacerbations in adults with COPD and type 2 inflammation. The study met its primary endpoint, with rademikibart reducing the rate of treatment failure by 81% and eliminating hospital readmissions or emergency department visits for new exacerbations through Week 4. The company plans to engage with the FDA to align on a Phase 3 registrational development program.
Peoples Bancorp Signs $728M M&A Deal with Capital Bancorp, Inc.
Peoples Bancorp Inc. (PEBO) has entered into a definitive agreement to acquire Capital Bancorp, Inc. (CBNK) in an all-stock transaction valued at approximately $728.1 million. Capital shareholders will receive 1.11 shares of Peoples common stock for each share held, creating a combined financial services franchise with approximately $14 billion in total assets. The merger expands Peoples' presence into the Washington, D.C. and Baltimore markets and adds nationwide specialty business segments including digital consumer credit and government-guaranteed lending.
Value
$728M
Counterparty
Capital Bancorp, Inc.
Earnings call
Sep 30, 2026, 10:00 AM ET
“We were looking for a transaction and a partner that strengthens our franchise well beyond scale alone, and Capital does exactly that. Its commercial banking franchise deepens our presence in the attractive Washington, D.C. and Baltimore markets, while OpenSky, Windsor Advantage and Capital Bank Home Loans add complementary nationwide businesses that further diversify our revenue and expand our growth opportunities.”
Tyler Wilcox, President and Chief Executive Officer of Peoples
“Peoples is an excellent strategic partner for Capital because it understands and values our unique business model and entrepreneurial culture.”
Edward F. "Ed" Barry, Chief Executive Officer of Capital
Capital Bancorp Signs $728M M&A Deal with Peoples Bancorp Inc.
Capital Bancorp, Inc. (CBNK) has entered into a definitive agreement to be acquired by Peoples Bancorp Inc. (PEBO) in an all-stock transaction valued at approximately $728.1 million. Capital shareholders will receive 1.11 shares of Peoples common stock for each share of Capital common stock held. The merger will create a combined financial services franchise with approximately $14 billion in total assets and expand Peoples' presence into the Washington, D.C. and Baltimore markets.
Hormel Foods Signs $1.05B M&A Deal with Brakebush Brothers, LLC
Hormel Foods has entered into a definitive agreement to acquire Brakebush Brothers, LLC, a leading value-added chicken company, for $1.055 billion in cash. The acquisition is intended to strengthen Hormel's position in the growing chicken protein category and expand its foodservice segment capabilities. The transaction is expected to close in the first quarter of Hormel's fiscal 2027.
Zedge, Inc. completed a private placement of 2,616,447 shares of Class B common stock and warrants to purchase 2,354,803 shares, raising $7.675 million in gross proceeds. The investment was led by Vice Chairman Howard Jonas through Chartwell Holding LLC, with participation from board member Elliot Gibber. The company intends to use the capital to accelerate the growth of its B2B AI data business, DataSeeds.AI.
Addentax Group Corp. entered into a private placement agreement with investor Chan Kai Sang to sell 520,834 shares of common stock at $4.80 per share. The transaction is expected to generate gross proceeds of approximately $2.5 million, which the company intends to use for general corporate purposes and strategic investments.
Marygold Companies M&A Deal with Madison Dearborn Partners
The Marygold Companies provided a status update on its previously announced definitive merger agreement with Madison Dearborn Partners (MDP), where MDP will acquire all outstanding shares for $2.00 per share. The company confirmed that stockholders representing 75% of the voting power have already delivered written consent approving the deal, and as a result, the company is no longer permitted to pursue alternative acquisition proposals.
OceanLight Acquisition Signs $1B M&A Deal with AIRE Inc.
OceanLight Acquisition Corporation (OCLT), a SPAC, has entered into a definitive merger agreement to acquire AIRE Inc., a home textile and green sleep technology company, at an enterprise value of $1.0 billion. Upon closing, the combined entity will be known as AIRE Global Group Inc. and is expected to remain listed on the Nasdaq. The transaction will involve the issuance of 100 million shares to AIRE shareholders at a value of $10.00 per share.
Reliance Global Group Divestiture to Altruis Benefit Management, LLC for $8M
Reliance Global Group's subsidiary, Altruis Benefit Consultants, sold substantially all assets of its employee benefits insurance agency business to Altruis Benefit Management, LLC for $8 million. The consideration consists of approximately $4.44 million in cash, a $3.1 million secured promissory note, and $461,729 in holdbacks, with potential earnout payments of up to $1 million based on future revenue growth. The transaction closed simultaneously with the signing of the asset purchase agreement on September 23, 2026.
Stonepeak-Plus Infrastructure Fund Capital Raise of $52.7M
Stonepeak-Plus Infrastructure Fund LP sold unregistered limited partnership units to third-party investors for approximately $52.7 million on September 1, 2026. The sale was part of a continuous private offering that has raised approximately $1.92 billion since its inception in May 2025.
ONE Nuclear Energy M&A Deal with ONE Nuclear Energy, LLC
ONE Nuclear Energy Inc. (formerly Hennessy Capital Investment Corp. VII) completed its business combination with ONE Nuclear Energy, LLC on September 23, 2026. As a result of the merger, ONE Nuclear Energy, LLC became a wholly owned subsidiary of the company, which now trades on Nasdaq under the ticker ONEN. The transaction was primarily funded through the issuance of new common stock to the members of the target company.
Silicon Valley Acquisition M&A Deal with EigenQ, Inc.
Silicon Valley Acquisition Corp. (SVAQ) and EigenQ, Inc. announced the public filing of a Form S-4 registration statement with the SEC regarding their previously announced business combination. The deal, which is expected to close in the fourth quarter of 2026, will result in EigenQ becoming a wholly owned subsidiary of a new Delaware corporation renamed EigenQ Holdings, Inc. (PubCo).
Cboe Global Markets Licensing Deal with S&P Opco, LLC
Cboe Global Markets has signed a 25-year extension of its exclusive licensing agreement with S&P Dow Jones Indices, securing the rights to list and trade S&P 500 index options through 2051. The agreement updates royalty fee terms starting in 2027 on a per-contract basis and includes cross-licenses for Volatility Indices (VIX) and other intellectual property. Management expects the updated fee structure to have a de minimis impact on 2027 net revenue growth relative to organic volume increases.
Marketaxess Holdings M&A Deal with Intercontinental Exchange, Inc.
MarketAxess and Intercontinental Exchange (ICE) have refiled their HSR Act premerger notifications to provide the DOJ with additional time for review, extending the waiting period to October 29, 2026. The companies continue to expect the merger to close in the first half of 2027, subject to stockholder approval and regulatory clearance. A special meeting for MarketAxess stockholders to vote on the merger is scheduled for October 29, 2026.
Kennedy Lewis Capital Company reported that it has raised approximately $677.6 million in total consideration to date through its ongoing $2.0 billion continuous public offering and private placement of common shares. As of August 31, 2026, the company's aggregate net asset value was $734.5 million with a portfolio fair value of $1.27 billion.
Tectonic Therapeutic announced favorable topline results from its Phase 1a clinical trial of TX2100, demonstrating that single ascending doses were generally safe and well-tolerated in healthy volunteers. The company also received FDA Fast Track designation and IND clearance to proceed with Phase 1b and Phase 2 trials in patients with Hereditary Hemorrhagic Telangiectasia (HHT).
Sino Green Land M&A Deal with Xing Da Plastics Sdn. Bhd. and Invent Fortune Sdn. Bhd.
Sino Green Land Corporation completed the acquisition of a 60% stake in Xing Da Plastics Sdn. Bhd. and 100% of Invent Fortune Sdn. Bhd. As consideration, the company issued approximately 41.3 million shares of its common stock to the sellers of both entities. These acquisitions represent a significant expansion of the company's asset base in the plastics and industrial sectors.
Counterparty
Xing Da Plastics Sdn. Bhd. and Invent Fortune Sdn. Bhd.
Heron Therapeutics Licensing Deal with Long Grove Pharmaceuticals, LLC
Heron Therapeutics entered into a multi-product Development and License Agreement with Long Grove Pharmaceuticals and Capstone Development Services. The agreement grants Heron an exclusive license to import, distribute, and market certain products in the U.S. in exchange for regulatory milestones, sales-based milestones, and royalty payments.
Elme Communities Divestiture to FPA Multifamily, LLC for $110M
Elme Communities completed the sale of its final two remaining properties, 3801 Connecticut Avenue and The Kenmore, to FPA Multifamily, LLC for a combined $110 million. These dispositions mark the completion of the company's property liquidation plan, leading to an upcoming voluntary delisting from the NYSE and a $1.74 per share special liquidating distribution.